{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:14Z","timestamp":1792184654580,"version":"4.4.0"},"reference-count":92,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This article is a clinical guide which discusses the \u201cstate-of-the-art\u201d usage of the classic monoamine oxidase inhibitor (MAOI) antidepressants (phenelzine, tranylcypromine, and isocarboxazid) in modern psychiatric practice. The guide is for all clinicians, including those who may not be experienced MAOI prescribers. It discusses indications, drug-drug interactions, side-effect management, and the safety of various augmentation strategies. There is a clear and broad consensus (more than 70 international expert endorsers), based on 6 decades of experience, for the recommendations herein exposited. They are based on empirical evidence and expert opinion\u2014this guide is presented as a new specialist-consensus standard. The guide provides practical clinical advice, and is the basis for the rational use of these drugs, particularly because it improves and updates knowledge, and corrects the various misconceptions that have hitherto been prominent in the literature, partly due to insufficient knowledge of pharmacology. The guide suggests that MAOIs should always be considered in cases of treatment-resistant depression (including those melancholic in nature), and prior to electroconvulsive therapy\u2014while taking into account of patient preference. In selected cases, they may be considered earlier in the treatment algorithm than has previously been customary, and should not be regarded as drugs of last resort; they may prove decisively effective when many other treatments have failed. The guide clarifies key points on the concomitant use of incorrectly proscribed drugs such as methylphenidate and some tricyclic antidepressants. It also illustrates the straightforward \u201cbridging\u201d methods that may be used to transition simply and safely from other antidepressants to MAOIs.<\/jats:p>","DOI":"10.1017\/s1092852922000906","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T06:45:14Z","timestamp":1657867514000},"page":"427-440","source":"Crossref","is-referenced-by-count":59,"title":["The prescriber\u2019s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression"],"prefix":"10.1017","volume":"28","author":[{"given":"Vincent","family":"Van den Eynde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wegdan R.","family":"Abdelmoemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magid M.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Amsterdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chittaranjan","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen B.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aartjan T.F.","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom K.","family":"Birkenh\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry B.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B.J.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Bodkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo I.","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bezalel","family":"Dantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boadie W.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan F.","family":"Est\u00e9vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalom S.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.M.","family":"Finberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Fochtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gotlib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Insel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens K.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Mago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Menkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Richelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henricus G.","family":"Ruh\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"S\u00e1iz-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Thase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J.L.M.","family":"van Balkom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Gillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"S1092852922000906_r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2017.09.008"},{"key":"S1092852922000906_r3","unstructured":"3. Zorgstandaard Depressieve stoornissen. https:\/\/www.ggzstandaarden.nl; 2018:26, 52."},{"key":"S1092852922000906_r17","doi-asserted-by":"publisher","DOI":"10.2337\/diab.18.8.538"},{"key":"S1092852922000906_r92","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320980573"},{"key":"S1092852922000906_r2","first-page":"50","article-title":"Moving on with monoamine oxidase inhibitors","volume":"19","author":"Bodkin","year":"2021","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"S1092852922000906_r37","first-page":"73","article-title":"The Prescriber\u2019s guide to the MAOI diet\u2014thinking through tyramine troubles","volume":"52","author":"Van den Eynde","year":"2022","journal-title":"Psychopharmacol Bull"},{"key":"S1092852922000906_r77","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00340"},{"key":"S1092852922000906_r26","unstructured":"26. Gillman, K . Monoamine oxidase inhibitors, dietary tyramine and drug interactions. Vol 13. PsychoTropical Commentaries; 2020:1\u201371."},{"key":"S1092852922000906_r63","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014572"},{"key":"S1092852922000906_r62","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000945"},{"key":"S1092852922000906_r35","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.05.007"},{"key":"S1092852922000906_r33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1965.tb02100.x"},{"key":"S1092852922000906_r20","unstructured":"20. Blom, MBJ , Birkenh\u00e4ger, TK , van den Broek, W , et al. Protocol Gebruik van klassieke MAO-remmers; 2013. www.dalecopharma.nl."},{"key":"S1092852922000906_r75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1192\/apt.bp.105.001966","article-title":"Recognising and managing antidepressant discontinuation symptoms","volume":"13","author":"Haddad","year":"2018","journal-title":"Adv Psychiat Treat"},{"key":"S1092852922000906_r86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2011.01695.x"},{"key":"S1092852922000906_r88","first-page":"366","article-title":"Hypertensie en orthostatische hypotensie bij gebruik van monoamine-oxidase(MAO)-remmers","volume":"59","author":"Zandee","year":"2017","journal-title":"Tijdschrift voor Psychiatrie"},{"key":"S1092852922000906_r1","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"S1092852922000906_r22","volume-title":"Brigg\u2019s Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk","author":"Briggs","year":"2021"},{"key":"S1092852922000906_r55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00004714-198206000-00010","article-title":"Adding a tricyclic antidepressant to a monoamine oxidase inhibitor","volume":"2","author":"Davidson","year":"1982","journal-title":"J Clin Psychopharmacol"},{"key":"S1092852922000906_r8","first-page":"1940","article-title":"Klassieke monoamineoxidaseremmers: niet geregistreerd, maar wel een plaats in de behandeling van depressies","volume":"147","author":"Nolen","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"key":"S1092852922000906_r54","first-page":"409","article-title":"Triiodothyronine potentiation of the antidepressant effect of phenelzine","volume":"49","author":"Joffe","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"S1092852922000906_r28","first-page":"1","article-title":"Antidepressant switching strategies","volume":"20","author":"Luft","year":"2013","journal-title":"Graylands Hospital Drug Bull"},{"key":"S1092852922000906_r13","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31820469ea"},{"key":"S1092852922000906_r85","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(83)90012-5"},{"key":"S1092852922000906_r89","first-page":"98","article-title":"Interaction between tranylcypromine and trazodone leading to a serotonin syndrome","volume":"148","author":"van Hunsel","year":"2013","journal-title":"Pharm Weekbl"},{"key":"S1092852922000906_r79","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196710000-00004"},{"key":"S1092852922000906_r49","unstructured":"49. Wilting, I , ter Pelwijk, NJ , van der Hurk, T , van Laarhoven, JHM , Collumbien, EAC . Pre en perioperatief gebruik van irreversibele MAO remmers; 2009. www.dalecopharma.nl."},{"key":"S1092852922000906_r81","doi-asserted-by":"publisher","DOI":"10.4172\/2375-4273.1000168"},{"key":"S1092852922000906_r80","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001505"},{"key":"S1092852922000906_r47","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852916000821"},{"key":"S1092852922000906_r32","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-021-02399-9"},{"key":"S1092852922000906_r74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1988.tb06293.x"},{"key":"S1092852922000906_r16","doi-asserted-by":"publisher","DOI":"10.2337\/diab.17.10.617"},{"key":"S1092852922000906_r11","first-page":"527","article-title":"Transdermal selegiline for the treatment of major depressive disorder","volume":"3","author":"Lee","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"S1092852922000906_r36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S1092852900016965","article-title":"Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants","volume":"13","author":"Stahl","year":"2008","journal-title":"CNS Spectr"},{"key":"S1092852922000906_r52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01575.x"},{"key":"S1092852922000906_r57","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001130"},{"key":"S1092852922000906_r56","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.118.544.301"},{"key":"S1092852922000906_r39","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg109"},{"key":"S1092852922000906_r42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02627.x"},{"key":"S1092852922000906_r5","first-page":"20","article-title":"Antidepressants in panic disorder","volume":"58","author":"Jefferson","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"S1092852922000906_r21","first-page":"128","article-title":"Treatment of depression in patients with diabetes mellitus","volume":"56","author":"Goodnick","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"S1092852922000906_r82","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800260024003"},{"key":"S1092852922000906_r50","doi-asserted-by":"publisher","DOI":"10.1159\/000468258"},{"key":"S1092852922000906_r91","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-8180(96)00175-4"},{"key":"S1092852922000906_r46","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei210"},{"key":"S1092852922000906_r45","volume-title":"Monoamine Oxidase Inhibitors: A Toolkit for Clinical Use","author":"Lott","year":"2021"},{"key":"S1092852922000906_r15","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198410000-00007"},{"key":"S1092852922000906_r69","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07607"},{"key":"S1092852922000906_r71","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1002324"},{"key":"S1092852922000906_r34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1106030108"},{"key":"S1092852922000906_r73","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31829465df"},{"key":"S1092852922000906_r19","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(89)90137-1"},{"key":"S1092852922000906_r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.11.016"},{"key":"S1092852922000906_r58","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001244"},{"key":"S1092852922000906_r44","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1212\/WNL.45.6.1039","article-title":"The use of sumatriptan in patients on monoamine oxidase inhibitors","volume":"45","author":"Diamond","year":"1995","journal-title":"Neurology"},{"key":"S1092852922000906_r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.04.003"},{"key":"S1092852922000906_r68","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0097-3"},{"key":"S1092852922000906_r78","doi-asserted-by":"publisher","DOI":"10.1177\/1039856216634824"},{"key":"S1092852922000906_r87","unstructured":"87. Choe, K , Fung, K , Lakhani, N , et al. MAOI Diet Recipe Book. https:\/\/sunnybrook.ca\/."},{"key":"S1092852922000906_r14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp-rj.2020.150402"},{"key":"S1092852922000906_r83","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(89)90001-1"},{"key":"S1092852922000906_r90","first-page":"20","article-title":"Trazodon in lage dosering veilig bij MAO-remmer","volume":"149","author":"Reinders","year":"2014","journal-title":"Pharm Weekbl"},{"key":"S1092852922000906_r43","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-012-0951-3"},{"key":"S1092852922000906_r64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.06.011"},{"key":"S1092852922000906_r67","unstructured":"67. Van den Eynde, V , Gillman, PK . Het gebruik van klassieke monoamineoxidase-inhibitoren (MAOIs) bij therapieresistente depressie. Verplichte gegrondheidsvoorwaarde bij een euthanasievraag? Euthanasierecht in Belgi\u00eb\u2014De wet in verandering (?). Story Publishers (Brepols); 2021:357\u2013365."},{"key":"S1092852922000906_r18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psychotherapy.1978.32.2.220"},{"key":"S1092852922000906_r48","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181e63033"},{"key":"S1092852922000906_r65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4088\/JCP.v58n0704","article-title":"Rapid conversion from one monoamine oxidase inhibitor to another","volume":"58","author":"Szuba","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"S1092852922000906_r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2008.06.025"},{"key":"S1092852922000906_r60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195607192550304"},{"key":"S1092852922000906_r61","first-page":"315","article-title":"Can disulfiram (Antabuse) be safely co-administered with the monoamine oxidase inhibitor (MAOI) antidepressants? Despite the ability of the major metabolite of disulfiram (diethyldithiocarbamate) to inhibit the enzyme dopamine beta-hydroxylase and a report of the induction in rats of central motor disturbances, convulsions, and death following the co-administration of tranylcypromine, there appears to be surprisingly little in the literature that directly addresses this question","volume":"9","author":"Ciraulo","year":"1989","journal-title":"J Clin Psychopharmacol"},{"key":"S1092852922000906_r59","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s40263-021-00837-6","article-title":"Cardiovascular effects of combining subcutaneous or intravenous esketamine and the MAO inhibitor tranylcypromine for the treatment of depression: a retrospective cohort study","volume":"35","author":"Ludwig","year":"2021","journal-title":"CNS Drugs."},{"key":"S1092852922000906_r9","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950080019003"},{"key":"S1092852922000906_r24","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0612-7"},{"key":"S1092852922000906_r38","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00832-x"},{"key":"S1092852922000906_r41","doi-asserted-by":"publisher","DOI":"10.1023\/B:CEMN.0000012725.31108.4a"},{"key":"S1092852922000906_r12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1176\/ajp.141.2.288","article-title":"Treatment of melancholia with tranylcypromine","volume":"141","author":"McGrath","year":"1984","journal-title":"Am J Psychiatry"},{"key":"S1092852922000906_r51","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.10.12.1076"},{"key":"S1092852922000906_r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.2937"},{"key":"S1092852922000906_r84","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(84)90025-9"},{"key":"S1092852922000906_r10","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.11.1869"},{"key":"S1092852922000906_r70","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1932-y"},{"key":"S1092852922000906_r27","first-page":"76","article-title":"Switching and stopping antidepressants","volume":"39","author":"Keks","year":"2016","journal-title":"Aust Prescr"},{"key":"S1092852922000906_r7","unstructured":"7. Gelenberg, AJ , Freeman, MP , Markowitz, JC , et al. APA: Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 3rd ed.; 2010. http:\/\/www.psychiatryonline.com."},{"key":"S1092852922000906_r25","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199426030-00004"},{"key":"S1092852922000906_r4","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m05041blu"},{"key":"S1092852922000906_r31","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.77a.09118"},{"key":"S1092852922000906_r76","doi-asserted-by":"publisher","DOI":"10.1177\/2045125311413497"},{"key":"S1092852922000906_r72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0032-1333265","article-title":"Withdrawal and discontinuation phenomena associated with tranylcypromine: a systematic review","volume":"46","author":"Gahr","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"S1092852922000906_r66","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000809"},{"key":"S1092852922000906_r53","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199958020-00016"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852922000906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T04:11:06Z","timestamp":1691640666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852922000906\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1092852922000906"],"URL":"https:\/\/doi.org\/10.1017\/s1092852922000906","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]}}}